A 2-nitroimidazole carbamate prodrug of 5-amino-1-(chloromethyl)-3-[(5,6,7-trimethoxyindol-2-yl)carbonyl]-1,2-dihydro-3H-benz[e]indole (amino-seco-CBI-TMI) for use with ADEPT and GDEPT
- 2 August 1999
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (15), 2237-2242
- https://doi.org/10.1016/s0960-894x(99)00381-9
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Gene-directed enzyme prodrug therapy: a review of enzyme/prodrug combinationsExpert Opinion on Investigational Drugs, 1997
- Synthesis of an aminopropyl analog of the experimental anticancer drug tallimustine, and activation of its 4-nitrobenzylcarbamoyl prodrug by nitroreductase and NADHBioorganic & Medicinal Chemistry Letters, 1997
- Mustard Prodrugs for Activation by Escherichia coli Nitroreductase in Gene-Directed Enzyme Prodrug TherapyJournal of Medicinal Chemistry, 1997
- Antibody-Enzyme Conjugates for Cancer TherapyJNCI Journal of the National Cancer Institute, 1996
- A novel enediyne prodrug for antibody-directed enzyme prodrug therapy (ADEPT) using E. coli B nitroreductaseBioorganic & Medicinal Chemistry Letters, 1995
- VDEPT: An enzyme/prodrug gene therapy approach for the treatment of metastatic colorectal cancerAdvanced Drug Delivery Reviews, 1995
- Facile Reduction of Carboxylic Acid Imidazolides to Primary Alcohols in the Presence of WaterSynlett, 1995
- Drug residue formation from ronidazole, a 5-nitroimidazole. VIII. Identification of the 2-methylene position as a site of protein alkylationChemico-Biological Interactions, 1992
- The role of catalytic superoxide formation in the O2 inhibition of nitroreductaseBiochemical and Biophysical Research Communications, 1975
- Synthesis of 1‐alkyl‐2‐nitroimidazole‐5‐carboxaldehydesJournal of Heterocyclic Chemistry, 1972